NCT06463054 Testing an Intergenerational Model of Suicide Risk in Mother-child Dyads
| NCT ID | NCT06463054 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pittsburgh |
| Condition | Emotion Regulation |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2024-04-01 |
| Primary Completion | 2028-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2024-04-01 with a primary completion date of 2028-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators are interested in learning more about how the role of mothers' emotions has on the transmission of suicide risk to children. Eligible participants will be invited to participate in a baseline assessment, and 4 follow-up assessments in the next year. This research study is a randomized control trial. Participants that choose to enroll are randomly assigned, that is by chance (like by flipping a coin) to receive DBT Skills Training or treatment as usual (TAU). Participants may also be selected for DBT skills training, it which would occur once a week for 6 months.
Eligibility Criteria
Inclusion Criteria: * Biological mothers with legal custody of target child between 9-11 * Confirmed lifetime Biological mothers with legal custody of target child between 9-11 * Confirmed lifetime history of suicidal behavior for mothers of suicidal behavior for mothers Exclusion Criteria: * Any mothers and children with major medical illnesses that might be associated with organic personality changes or ER difficulties (e.g. Parkinson's Disease, seizure disorders) * Cardiac nervous system abnormalities that would influence physiological readings * Previous DBT (Dialectical Behavior Therapy) in the last six months
Contact & Investigator
Stephanie D Step, PhD
PRINCIPAL INVESTIGATOR
University of Pittsburgh
Frequently Asked Questions
Who can join the NCT06463054 clinical trial?
This trial is open to participants of all sexes, studying Emotion Regulation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06463054 currently recruiting?
Yes, NCT06463054 is actively recruiting participants. Contact the research team at bresjl@upmc.edu for enrollment information.
Where is the NCT06463054 trial being conducted?
This trial is being conducted at Pittsburgh, United States.
Who is sponsoring the NCT06463054 clinical trial?
NCT06463054 is sponsored by University of Pittsburgh. The principal investigator is Stephanie D Step, PhD at University of Pittsburgh. The trial plans to enroll 150 participants.